You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
Cochrane database of systematic reviews, April 2006
Angela C Webster, Vincent WS Lee, Jeremy R Chapman, Jonathan C Craig
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||18||26%|
|Student > Bachelor||11||16%|
|Student > Ph. D. Student||8||12%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||40||59%|
|Nursing and Health Professions||5||7%|
|Biochemistry, Genetics and Molecular Biology||3||4%|
|Pharmacology, Toxicology and Pharmaceutical Science||2||3%|